CERBONE, LUIGI
CERBONE, LUIGI
100007 - Dipartimento di Medicina interna e specialità mediche
An overview of osimertinib as a treatment of non-small cell lung cancer (NSCLC): an update
2021-01-01 Cerbone, L.; Benitez, J. C.; Planchard, D.; Genova, C.
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib
2022-01-01 Rebuzzi, Sara Elena; Cerbone, Luigi; Signori, Alessio; Santoni, Matteo; Murianni, Veronica; De Giorgi, Ugo; Procopio, Giuseppe; Porta, Camillo; Milella, Michele; Basso, Umberto; Massari, Francesco; Maruzzo, Marco; Iacovelli, Roberto; Battelli, Nicola; Carmisciano, Luca; Banna, Giuseppe Luigi; Buti, Sebastiano; Fornarini, Giuseppe
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials
2018-01-01 Messina, Carlo; Cattrini, Carlo; Buzzatti, Giulia; Cerbone, Luigi; Zanardi, Elisa; Messina, Marco; Boccardo, Francesco
Combination therapy in metastatic renal cell carcinoma: Back to the future?
2020-01-01 Cerbone, Luigi; Cattrini, Carlo; Vallome, Giacomo; Latocca, Maria Maddalena; Boccardo, Francesco; Zanardi, Elisa
EFFICACY AND SAFETY OF SUNITINIB AND EVEROLIMUS AS FRONTLINE TREATMENT FOR NON-CC-RCC: A POOLED-ANALYSIS FROM RANDOMIZED TRIALS
2018-01-01 Messina, C; Messina, M; Cattrini, C; Cerbone, L; Mastrocinque, G; Zanardi, E; Spatafora, P
Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study
2018-01-01 Cattrini, Carlo; Cerbone, Luigi; Rubagotti, Alessandra; Zinoli, Linda; Latocca, Maria Maddalena; Buzzatti, Giulia; Vallome, Giacomo; Rizzo, Fabio; Cavo, Alessia; Beshiri, Kristi; Soldato, Davide; Messina, Carlo; Zanardi, Elisa; Boccardo, Francesco
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study
2019-01-01 Cattrini, Carlo; Cerbone, Luigi; Rubagotti, Alessandra; Zinoli, Linda; Latocca, Maria Maddalena; Messina, Carlo; Zanardi, Elisa; Boccardo, Francesco
Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life: A single institution experience
2019-01-01 Vallome, Giacomo; Cattrini, Carlo; Messina, Carlo; Cerbone, Luigi; Boccardo, Francesco; Zanardi, Elisa
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients
2019-01-01 Cattrini, Carlo; Rubagotti, Alessandra; Zinoli, Linda; Cerbone, Luigi; Zanardi, Elisa; Capaia, Matteo; Barboro, Paola; Boccardo, Francesco
Targeting androgen-independent pathways: new chances for patients with prostate cancer?
2017-01-01 Cattrini, C.; Zanardi, E.; Vallome, Giacomo; Cavo, A.; Cerbone, Luigi; Di Meglio, A.; Fabbroni, Chiara; Latocca, M. M.; Rizzo, Fabio; Messina, C.; Rubagotti, A.; Barboro, P.; Boccardo, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| An overview of osimertinib as a treatment of non-small cell lung cancer (NSCLC): an update | 1-gen-2021 | Cerbone, L.; Benitez, J. C.; Planchard, D.; Genova, C. | |
| Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib | 1-gen-2022 | Rebuzzi, Sara Elena; Cerbone, Luigi; Signori, Alessio; Santoni, Matteo; Murianni, Veronica; De Giorgi, Ugo; Procopio, Giuseppe; Porta, Camillo; Milella, Michele; Basso, Umberto; Massari, Francesco; Maruzzo, Marco; Iacovelli, Roberto; Battelli, Nicola; Carmisciano, Luca; Banna, Giuseppe Luigi; Buti, Sebastiano; Fornarini, Giuseppe | |
| CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials | 1-gen-2018 | Messina, Carlo; Cattrini, Carlo; Buzzatti, Giulia; Cerbone, Luigi; Zanardi, Elisa; Messina, Marco; Boccardo, Francesco | |
| Combination therapy in metastatic renal cell carcinoma: Back to the future? | 1-gen-2020 | Cerbone, Luigi; Cattrini, Carlo; Vallome, Giacomo; Latocca, Maria Maddalena; Boccardo, Francesco; Zanardi, Elisa | |
| EFFICACY AND SAFETY OF SUNITINIB AND EVEROLIMUS AS FRONTLINE TREATMENT FOR NON-CC-RCC: A POOLED-ANALYSIS FROM RANDOMIZED TRIALS | 1-gen-2018 | Messina, C; Messina, M; Cattrini, C; Cerbone, L; Mastrocinque, G; Zanardi, E; Spatafora, P | |
| Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study | 1-gen-2018 | Cattrini, Carlo; Cerbone, Luigi; Rubagotti, Alessandra; Zinoli, Linda; Latocca, Maria Maddalena; Buzzatti, Giulia; Vallome, Giacomo; Rizzo, Fabio; Cavo, Alessia; Beshiri, Kristi; Soldato, Davide; Messina, Carlo; Zanardi, Elisa; Boccardo, Francesco | |
| Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study | 1-gen-2019 | Cattrini, Carlo; Cerbone, Luigi; Rubagotti, Alessandra; Zinoli, Linda; Latocca, Maria Maddalena; Messina, Carlo; Zanardi, Elisa; Boccardo, Francesco | |
| Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life: A single institution experience | 1-gen-2019 | Vallome, Giacomo; Cattrini, Carlo; Messina, Carlo; Cerbone, Luigi; Boccardo, Francesco; Zanardi, Elisa | |
| Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients | 1-gen-2019 | Cattrini, Carlo; Rubagotti, Alessandra; Zinoli, Linda; Cerbone, Luigi; Zanardi, Elisa; Capaia, Matteo; Barboro, Paola; Boccardo, Francesco | |
| Targeting androgen-independent pathways: new chances for patients with prostate cancer? | 1-gen-2017 | Cattrini, C.; Zanardi, E.; Vallome, Giacomo; Cavo, A.; Cerbone, Luigi; Di Meglio, A.; Fabbroni, Chiara; Latocca, M. M.; Rizzo, Fabio; Messina, C.; Rubagotti, A.; Barboro, P.; Boccardo, F. |